| Extraction, purification and characterization of lipopolysaccharide from Escherichia coli and Salmonella typhi S Rezania, N Amirmozaffari, B Tabarraei, M Jeddi-Tehrani, O Zarei, ... Avicenna journal of medical biotechnology 3 (1), 3, 2011 | 183 | 2011 |
| Histamine H3 receptor antagonists/inverse agonists: Where do they go? N Ghamari, O Zarei, JA Arias-Montaño, D Reiner, S Dastmalchi, H Stark, ... Pharmacology & Therapeutics 200, 69-84, 2019 | 72 | 2019 |
| A simple and rapid protocol for producing yeast extract from Saccharomyces cerevisiae suitable for preparing bacterial culture media O Zarei, S Dastmalchi, M Hamzeh-Mivehroud Iranian journal of pharmaceutical research: IJPR 15 (4), 907, 2016 | 69 | 2016 |
| IL-6, IL-10 and IL-17 gene polymorphisms in Iranian women with recurrent miscarriage M Bahadori, S Zarei, AH Zarnani, O Zarei, F Idali, R Hadavi, ... Iranian Journal of Immunology 11 (2), 97-104, 2014 | 56 | 2014 |
| Mycoplasma genitalium and cancer: a brief review O Zarei, S Rezania, A Mousavi Asian Pac J Cancer Prev 14 (6), 3425-8, 2013 | 42 | 2013 |
| Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects N Ghamari, O Zarei, D Reiner, S Dastmalchi, H Stark, ... Chemical Biology & Drug Design 93 (5), 832-843, 2019 | 32 | 2019 |
| The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligation S Rezania, N Amirmozaffari, N Rashidi, E Mirzadegan, S Zarei, ... Cancer Cell International 14, 1-14, 2014 | 24 | 2014 |
| Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery O Zarei, S Benvenuti, F Ustun-Alkan, M Hamzeh-Mivehroud, S Dastmalchi Journal of cancer research and clinical oncology 142, 2429-2446, 2016 | 21 | 2016 |
| Peptide-based polyclonal antibody production against P110 protein of Mycoplasma genitalium O Zarei, GR Irajian, AH Zarnani, L Chamani-Tabriz, S Emami, ... Avicenna Journal of Medical Biotechnology 3 (2), 79, 2011 | 15 | 2011 |
| In silico and in vitro studies of two non‐imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes N Ghamari, S Dastmalchi, O Zarei, JA Arias‐Montaño, D Reiner, ... Chemical Biology & Drug Design 95 (2), 279-290, 2020 | 13 | 2020 |
| Monoclonal antibody against ROR1 induces apoptosis in human bladder carcinoma cells AA Bayat, N Sadeghi, R Fatemi, MR Nowroozi, SO Moghadam, ... Avicenna Journal of Medical Biotechnology 12 (3), 165, 2020 | 12 | 2020 |
| Characterizing the hot spots involved in RON-MSPβ complex formation using in silico alanine scanning mutagenesis and molecular dynamics simulation O Zarei, M Hamzeh-Mivehroud, S Benvenuti, F Ustun-Alkan, S Dastmalchi Advanced pharmaceutical bulletin 7 (1), 141, 2017 | 8 | 2017 |
| Structure-based discovery of novel small molecule inhibitors of platelet-derived growth factor-B O Zarei, N Sarri, S Dastmalchi, F Zokai, N Papadopoulos, J Lennartsson, ... Bioorganic Chemistry 94, 103374, 2020 | 7 | 2020 |
| Production and characterization of polyclonal antibody against a synthetic peptide from β-actin protein N Amini, MN Vishteh, O Zarei, R Hadavi, N Ahmadvand, H Rabbani, ... Iranian Journal of Basic Medical Sciences 17 (6), 396, 2014 | 6 | 2014 |
| Ligand‐based Discovery of Novel Small Molecule Inhibitors of RON Receptor Tyrosine Kinase O Zarei, N Faham, H Vankayalapati, SL Raeppel, AL Welm, ... Molecular Informatics 41 (1), 2000181, 2022 | 5 | 2022 |
| Effects of phenothiazines on aldehyde oxidase activity towards aldehydes and N-heterocycles: an in vitro and in silico study F Deris-Abdolahpour, L Abdolalipouran-Sadegh, S Dastmalchi, ... European Journal of Drug Metabolism and Pharmacokinetics 44, 275-286, 2019 | 5 | 2019 |
| The Association of Cell Surface Fibromodulin Expression and Bladder Carcinoma: Anti-FMOD induce apoptosis in bladder cancer AA Bayat, N Sadeghi, A Salimi, G Fazli, MR Nowroozi, SO Moghadam, ... Urology journal 19 (03), 189-195, 2022 | 4 | 2022 |
| Cell surface vimentin detection in cancer cells by peptide-based monoclonal antibody N Sadeghi, G Fazli, AA Bayat, R Fatemi, N Ebrahimnejhad, A Salimi, ... Avicenna journal of medical biotechnology 15 (2), 68, 2023 | 3 | 2023 |
| Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode O Zarei, S Benvenuti, F Ustun-Alkan, M Hamzeh-Mivehroud, S Dastmalchi Journal of molecular modeling 23, 1-17, 2017 | 3 | 2017 |
| An alignment-independent three-dimensional quantitative structure–activity relationship study on ron receptor tyrosine kinase inhibitors O Zarei, SL Raeppel, M Hamzeh-Mivehroud Journal of bioinformatics and computational biology 20 (03), 2250015, 2022 | 2 | 2022 |
